Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of bupleurum longiradiatum particle to preparing medicament for treating fatty liver

A technology of fatty liver and Bupleurum, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve problems such as unsatisfactory therapeutic effect

Inactive Publication Date: 2010-06-02
JINGHUA PHARMA GRP
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Existing medicines for the treatment of fatty liver are often based on western medicine, and the curative effect is not ideal, and the existing Dabuihu decoction is only used for other conventional diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] 1. Preparation of large diesel particles:

[0021] Take bupleurum, scutellaria baicalensis, peony, ginger pinellia, fried citrus aurantium, ginger, and jujube medicinal materials, add 5 to 15 times the total weight of the above medicinal materials (for example, 5 times, 10 times, 15 times) to decoct, filter, and concentrate into Relative density 1.05~1.25 concentrated solution I; Get rhubarb, and add 30~90% ethanol (example 30%, 60%, 90%) equivalent to 5~15 times of rhubarb weight (example 5 times, 10 times, 15 times) Reflux extraction, recover ethanol from the extract, and obtain concentrated liquid II with a relative density of 1.05 to 1.25; combine concentrated liquid I and concentrated liquid II, stir well, spray dry, add auxiliary materials and flavoring agents to granulate, dry, inspect, and pack to obtain Dachai Hu particles.

[0022] The consumption of above-mentioned drug raw material is calculated as by weight percentage:

[0023] Bupleurum 15~22% (Example 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of a bupleurum longiradiatum particle to preparing a medicament for treating fatty liver and provides a new medicament purpose of a bupleurum longiradiatum particle. The effect on treating fatty liver is good. According to the use of about 100 clinical cases, the efficiency is more than 85 percent.

Description

Technical field: [0001] The present invention relates to the use of a medicine. Background technique: [0002] Existing medicines for the treatment of fatty liver are often based on western medicine, and the curative effect is not ideal, and the existing Dabuihu decoction is only used for other conventional diseases. Invention content: [0003] The purpose of the present invention is to provide the application of Da Bupleurum Granules in the preparation of medicaments for treating fatty liver. [0004] Technical solution of the present invention is: [0005] The invention discloses an application of Dacpleurum granule in the preparation of a medicine for treating fatty liver. [0006] The bupleurum granules are made from the following medicinal materials in percentage by weight: [0007] Bupleurum 15-22% [0008] Scutellaria baicalensis 8~14% [0009] Peony 8~14% [0010] Pinellia 8~14% [0011] Citrus aurantium 8~14% [0012] Rhubarb 6-10% [0013] Ginger 5-20% ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61K9/16A61P1/16
Inventor 朱春林周云中张志芬王兆龙卢娜娜
Owner JINGHUA PHARMA GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products